As of February 2023 Catalent has a market cap of $9.84 Billion. This makes Catalent the world's 1537th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $9.84 B | 21.57% |
2022 | $8.10 B | -64.65% |
2021 | $22.91 B | 33.71% |
2020 | $17.14 B | 107.95% |
2019 | $8.24 B | 81.53% |
2018 | $4.54 B | -16.81% |
2017 | $5.45 B | 62.28% |
2016 | $3.36 B | 7.91% |
2015 | $3.11 B | -9.71% |
2014 | $3.45 B |
On Feb 1st, 2023 the market cap of Catalent was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Supernus Pharmaceuticals
SUPN | $2.24 B | -77.17% | ๐บ๐ธ USA |
![]() Jazz Pharmaceuticals JAZZ | $9.93 B | 0.88% | ๐ฎ๐ช Ireland |
![]() Aerie Pharmaceuticals AERI | $0.75 B | -92.35% | ๐บ๐ธ USA |
![]() Intercept Pharmaceuticals
ICPT | $0.77 B | -92.11% | ๐บ๐ธ USA |